ArticleScience advances2019

PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer.

Qun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.